Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver.

× No keyword cloud information.

5 in total

1. A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma.

Authors: Imane El Dika; Robert J Mayer; Alan P Venook; Marinela Capanu; Michael P LaQuaglia; Rachel Kobos; Allison F O'Neill; Joanne F Chou; Michele Ly; Celina Ang; Eileen M O'Reilly; John D Gordan; Ghassan K Abou-Alfa
Journal: Oncologist Date: 2020-05-26

2. Progression after Immunotherapy for Fibrolamellar Carcinoma.

Authors: Ulrike Bauer; Carolin Mogler; Rickmer F Braren; Hana Algül; Roland M Schmid; Ursula Ehmer
Journal: Visc Med Date: 2019-02-12

Review 3. Clinical significance of FBXW7 loss of function in human cancers.

Authors: Jingyi Fan; Marcia Bellon; Mingyi Ju; Lin Zhao; Minjie Wei; Liwu Fu; Christophe Nicot
Journal: Mol Cancer Date: 2022-03-26 Impact factor: 27.401

Review 4. Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event.

Authors: Walaa Abdelhamed; Mohamed El-Kassas
Journal: World J Gastrointest Oncol Date: 2022-06-15

5. Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.

Authors: Anastasia Lemekhova; Daniel Hornuss; Georgios Polychronidis; Philipp Mayer; Christian Rupp; Thomas Longerich; Karl-Heinz Weiss; Markus Büchler; Arianeb Mehrabi; Katrin Hoffmann
Journal: World J Surg Oncol Date: 2020-05-12 Impact factor: 2.754

5 in total